Chime Financial Falls as Investors Reassess Bank Deal and Recent Run-Up

Chime Financial, Inc. (CHYM) is down 6.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The pullback appears tied to investors reassessing Chime’s pending bank acquisition after last week’s sharp rally, with the market weighing execution and regulatory approval risk against the long-term strategic upside. This could also be because the stock had recently pushed to fresh post-IPO highs, making it vulnerable to profit-taking in a weaker tape for financial shares.

Details:

Chime disclosed on September 8 that it agreed to acquire Central Service Corporation, the parent of Stride Bank, for $590 million in cash, subject to customary approvals including the Federal Reserve and the Office of the Comptroller of the Currency.

The company said Stride would become Chime Bank, N.A., giving Chime a faster route to full-stack ownership than pursuing a de novo bank charter.

Chime’s second-quarter results in August were strong, with 27% year-over-year revenue growth, 10.4 million active members, a second straight quarter of GAAP profitability, and a higher full-year outlook.

With the stock having surged after the bank deal announcement and recently trading near a new high, today’s decline looks consistent with a giveback move as investors digest integration, capital, and regulatory questions.

Sources:

SEC, Chime, AP

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHYM Insider Trading Activity

$CHYM insiders have traded $CHYM stock on the open market 283 times in the past 6 months. Of those trades, 0 have been purchases and 283 have been sales.

Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:

GLOBAL ADVISORS LTD DST has made 0 purchases and 252 sales selling 26,067,866 shares for an estimated $851,768,610.
CHRISTOPHER R BRITT (Chief Executive Officer) has made 0 purchases and 10 sales selling 850,000 shares for an estimated $26,271,578.
SHAWN T CAROLAN has made 0 purchases and 6 sales selling 579,313 shares for an estimated $19,194,539.
RYAN A KING (Co-Founder) has made 0 purchases and 4 sales selling 417,421 shares for an estimated $12,841,242.
JAMES FEUILLE has made 0 purchases and 3 sales selling 351,890 shares for an estimated $11,611,184.
MATTHEW S NEWCOMB (Chief Financial Officer) has made 0 purchases and 2 sales selling 65,000 shares for an estimated $1,961,000.
AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 4 sales selling 39,505 shares for an estimated $1,192,529.
ADAM B FRANKEL (General Counsel) has made 0 purchases and 2 sales selling 6,000 shares for an estimated $106,500.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CHYM Hedge Fund Activity

We have seen 178 institutional investors add shares of $CHYM stock to their portfolio, and 122 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ICONIQ CAPITAL, LLC removed 11,064,137 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $226,593,525
COATUE MANAGEMENT LLC removed 10,071,992 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $206,274,396
BLACKROCK, INC. added 9,819,060 shares (+688.9%) to their portfolio in Q2 2026, for an estimated $201,094,348
TIGER GLOBAL MANAGEMENT LLC removed 8,908,454 shares (-62.8%) from their portfolio in Q2 2026, for an estimated $182,445,137
POINT72 ASSET MANAGEMENT, L.P. removed 4,586,956 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $85,913,685
SCGE MANAGEMENT, L.P. removed 4,181,827 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $85,643,816
CITADEL ADVISORS LLC removed 3,709,869 shares (-55.9%) from their portfolio in Q1 2026, for an estimated $69,485,846

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CHYM Price Targets

Multiple analysts have issued price targets for $CHYM recently. We have seen 5 analysts offer price targets for $CHYM in the last 6 months, with a median target of $28.0.

Here are some recent targets:

Nik Cremo from Barclays set a target price of $26.0 on 07/08/2026
Joseph Vafi from Canaccord Genuity set a target price of $40.0 on 05/11/2026
Cassie Chan from Wells Fargo set a target price of $28.0 on 05/07/2026
Andrew Bauch from BMO Capital set a target price of $30.0 on 04/22/2026
Giuliano Bologna from Compass Point set a target price of $27.0 on 04/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.